Education
About Us
Working with TipRanks
Follow Us
Century Therapeutics (IPSC)
NASDAQ:IPSC
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.59M | $ 2.23M | $ 5.20M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 6.59M | $ 2.23M | $ 5.20M | $ -4.58M | $ -1.75M |
| Operating Income | $ -138.14M | $ -146.55M | $ -133.83M | $ -94.88M | $ -49.18M |
| EBITDA | $ -111.47M | $ -121.21M | $ -121.20M | $ -89.92M | $ -51.44M |
| Net Income | $ -126.57M | $ -136.67M | $ -130.93M | $ -95.82M | $ -53.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 189.29M | $ 172.74M | $ 315.50M | $ 222.88M | $ 75.75M |
| Total Assets | $ 353.22M | $ 360.69M | $ 486.54M | $ 437.38M | $ 106.78M |
| Total Debt | $ 53.83M | $ 48.17M | $ 49.41M | $ 25.12M | $ 21.55M |
| Net Debt | $ -4.61M | $ 847.00K | $ -34.85M | $ -31.33M | $ -5.66M |
| Total Liabilities | $ 191.85M | $ 175.94M | $ 183.81M | $ 41.14M | $ 213.19M |
| Stockholders' Equity | $ 161.36M | $ 184.75M | $ 302.74M | $ 396.24M | $ -106.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -110.29M | $ -102.08M | $ -16.55M | $ -133.97M | $ -51.09M |
| Operating Cash Flow | $ -110.14M | $ -88.35M | $ 14.05M | $ -89.00M | $ -41.27M |
| Investing Cash Flow | $ 47.48M | $ 61.13M | $ -13.13M | $ -298.34M | $ -22.76M |
| Financing Cash Flow | $ 74.56M | $ -9.72M | $ 27.16M | $ 417.77M | $ 47.69M |